Seelos Therapeutics Inc
NASDAQ:SEEL

Watchlist Manager
Seelos Therapeutics Inc Logo
Seelos Therapeutics Inc
NASDAQ:SEEL
Watchlist
Price: 0.39 USD -27.79%
Market Cap: 100k USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

SEEL Price Targets Summary
Seelos Therapeutics Inc

There are no price targets for SEEL.
SEEL Lowest Forecast
Wall Street Target
Not Available
SEEL Average Forecast
Wall Street Target
Not Available
SEEL Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Seelos Therapeutics Inc Competitors:
Price Targets
185750
Chong Kun Dang Pharmaceutical Corp
47% Upside
C
867
China Medical System Holdings Ltd
2% Upside
ALM
Almirall SA
15% Upside
H
600566
Hubei Jumpcan Pharmaceutical Co Ltd
18% Upside
185750
Chong Kun Dang Pharmaceutical Corp
47% Upside
C
867
China Medical System Holdings Ltd
2% Upside
ALM
Almirall SA
15% Upside
H
600566
Hubei Jumpcan Pharmaceutical Co Ltd
18% Upside
LUPIN
Lupin Ltd
14% Upside
4506
Sumitomo Pharma Co Ltd
15% Downside
1177
Sino Biopharmaceutical Ltd
7% Upside
MDWD
Mediwound Ltd
41% Upside

Revenue
Forecast

Revenue Estimate
Seelos Therapeutics Inc

For the last 8 years the compound annual growth rate for Seelos Therapeutics Inc's revenue is -9%. The projected CAGR for the next 2 years is 263%.

-9%
Past Growth
263%
Estimated Growth
Estimates Accuracy
18%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Seelos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
8%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Seelos Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-97%
Average Miss
What are analyst estimates?

See Also

Summary
SEEL intrinsic value, competitors valuation, and company profile.
DCF Valuation
SEEL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SEEL stock valuation using valuation multiples.
Wall Street Estimates
SEEL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SEEL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SEEL's stock price target?
Not Available

SEEL doesn't have any price targets made by Wall Street professionals.

What is Seelos Therapeutics Inc's Revenue forecast?
Projected CAGR
263%

For the last 8 years the compound annual growth rate for Seelos Therapeutics Inc's revenue is -9%. The projected CAGR for the next 2 years is 263%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 259,900+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.